![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Erregierre S.p.a. San Paolo D'argon It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Raloxifene hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-205 - Rev 00
This Chemical Type CEP, issued on September 06, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2375 associated with this CEP further emphasizes